Sex matters when it comes to venous thromboembolism (VTE). We defined 5P's–period, pill,
prognosis, pregnancy, and postthrombotic syndrome–that should be discussed with young …

During pregnancy, physiologic and anatomic changes can complicate the diagnosis of
venous thromboembolism (VTE) as well as the management of patients with a high risk of or …

The lifetime risk of venous thromboembolism (VTE) is slightly higher in women than in men.
There are several issues related to VTE that are unique to women. Combined hormonal …

The role of gender in the causation of first and recurrent venous thromboembolism (VTE) is
uncertain. The use of hormonal therapy and pregnancy has been associated with VTE in …

OBJECTIVE: to identify risk factors for venous thromboembolism (VTE) in the peripartum
period and to provide guidelines for risk assessment and thromboprophylactic measures for …

The risk of venous thromboembolism (VTE) varies throughout a woman's life and is
associated primarily with underlying hormonal exposure. Alteration in hemostatic …

Knowledge of the absolute and relative risk of venous thromboembolism (VTE) in and
around pregnancy would be crucial in identifying when to commence and cease …

Pregnancy-associated venous thromboembolism (VTE) is a leading cause of maternal
mortality, but is relatively uncommon. It is clear that the antepartum and postpartum periods …

Background Pregnancy-related venous thromboembolism is a leading cause of maternal
morbidity and mortality, and thromboprophylaxis is indicated in pregnant and post-partum …

One to 2 pregnant women in 1000 will experience venous thromboembolism (VTE) during
pregnancy or postpartum. Pulmonary embolism (PE) is a leading cause of maternal …